The Status and Future of the Shift to Non-Personal Promotion in Pharma Marketing
It’s been a year since the onset of COVID-19 upended the way we live our lives and conduct our business. It’s now clear that non-personal promotion (NPP) with providers has cemented a larger role in the pharma marketing mix – regardless of whether we’re able to regain a semblance of pre-COVID interaction in 2021.
As pharma continues to grapple with reduced airtime with physicians, NPP commands a more significant share of 2021 marketing budgets, and organizations search for ways to connect in a wholly virtual world. Opportunities to innovate abound.
In this roundtable, we’ll discuss what we’re hearing about practical methods that pharma is using to balance personal and non-personal promotion, as well as the importance of interconnectivity across virtual digital platforms.
In under just 60 minutes you'll learn:
The biggest challenges pharma faced in 2020 while shifting to a virtual mindset—and what challenges will persist in 2021
How changing patient populations and personalized care impact customer engagement models
How existing digital technologies support new customer engagement model
Panelists
Meet the thought leaders




